Pulmonary Toxicity Following Proton Therapy for Thoracic Lymphoma

被引：15
|
作者：
Nanda, Ronica [1 ]
Flampouri, Stella [1 ]
Mendenhall, Nancy P. [1 ]
Indelicato, Daniel J. [1 ]
Jones, Lisa M. [2 ]
Seeram, Vandana K. [2 ]
Hoppe, Bradford S. [1 ]
机构：
[1] Univ Florida, Coll Med, Dept Radiat Oncol, Jacksonville, FL 32206 USA
[2] Univ Florida, Coll Med, Dept Med, Jacksonville, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
INTENSITY-MODULATED RADIOTHERAPY; MEDIASTINAL HODGKIN LYMPHOMA; CONFORMAL RADIATION-THERAPY; COMBINED-MODALITY THERAPY; INVOLVED-FIELD; PNEUMONITIS; OUTCOMES; CHEMOTHERAPY;
D O I：
10.1016/j.ijrobp.2017.04.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：494 / 497
页数：4
相关论文
共 50 条
  • [41] Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma
    Thomas, Theodore S.
    Luo, Suhong
    Reagan, Patrick M.
    Keller, Jesse W.
    Sanfilippo, Kristen M.
    Carson, Kenneth R.
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (01) : 69 - 74
  • [42] Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?
    Liao, Zhongxing
    Gandhi, Saumil J.
    Lin, Steven H.
    Bradley, Jeffrey
    SEMINARS IN RADIATION ONCOLOGY, 2018, 28 (02) : 114 - 124
  • [43] Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma
    Bates, James E.
    Terezakis, Stephanie
    Morris, Christopher G.
    Rao, Avani D.
    Sehgal, Shuchi
    Kumar, Rahul
    Vega, Raymond B. Mailhot
    Mendenhall, Nancy P.
    Hoppe, Bradford S.
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2022, 8 (03) : 21 - 27
  • [44] Proton therapy for thoracic reirradiation of non-small cell lung cancer
    Chao, Hann-Hsiang
    Berman, Abigail T.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (02) : 153 - 159
  • [45] Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma
    Way, Ashley
    Ozdemir, Savas
    Berges, Barbara
    Getman, Nataliya
    Liang, Xiaoying
    Mendenhall, Nancy P.
    Ma, Graham Collins
    Cutter, David
    Vega, Raymond B. Mailhot
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2022, 8 (04) : 76 - 81
  • [46] Outcomes of proton therapy to infradiaphragmatic sites in pediatric patients with Hodgkin lymphoma
    Jiang, Cecilia
    Kim, Michele
    Han, Xiaoyan
    Chelius, Monica
    Hoover, Travis
    Kersun, Leslie
    Reilly, Anne F.
    Hubbeling, Harper
    Cummings, Elizabeth
    Kurtz, Goldie
    Hill-Kayser, Christine
    Plastaras, John P.
    LaRiviere, Michael J.
    PEDIATRIC BLOOD & CANCER, 2024, 71 (12)
  • [47] Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity
    Jona, Adam
    Miltenyi, Zsofia
    Ujj, Zsofia
    Garai, Ildiko
    Szilasi, Maria
    Illes, Arpad
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (10) : 1291 - 1297
  • [48] Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma
    Sun, Haowei
    Atenafu, Eshetu G.
    Tsang, Richard
    Kukreti, Vishal
    Marras, Theodore K.
    Crump, Michael
    Kuruvilla, John
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2607 - 2614
  • [49] Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence
    Loap, Pierre
    Mirandola, Alfredo
    De Marzi, Ludovic
    Dendale, Remi
    Iannalfi, Alberto
    Vitolo, Viviana
    Barcellini, Amelia
    Filippi, Andrea Riccardo
    Jereczek-Fossa, Barbara Alicja
    Kirova, Youlia
    Orlandi, Ester
    CANCERS, 2021, 13 (15)
  • [50] Bleomycin in Hodgkin's Lymphoma - A Boon or a Bane? - A Retrospective Study of Bleomycin Pulmonary Toxicity in Hodgkin's Lymphoma
    Udupa, Chethana Babu K.
    Koteshwar, Prakashini
    Udupa, Karthik S.
    INDIAN JOURNAL OF PALLIATIVE CARE, 2019, 25 (04) : 523 - 526
12345